ArticleBJUI compass2025

Long-term outcome of transurethral laser ablation for recurrent non-muscle invasive bladder cancer: An EORTC risk-matched study.

Chase Peng Yun Ng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.